Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study

    July 2003 in “ Journal of Cutaneous Medicine and Surgery ”
    Jerry Shapiro
    Studysummary This study found that topical minoxidil solution is a safe treatment for androgenetic alopecia, with no increase in cardiovascular events or adverse pregnancy outcomes observed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.sagepub.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study European journal of cardiovascular prevention & rehabilitation · 2001
    2. Treatments for Androgenetic Alopecia and Alopecia Areata Drugs · 2001
    3. Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment Journal of The American Academy of Dermatology · 1999
    4. The Psychosocial Consequences of Androgenetic Alopecia: A Review of the Research Literature British Journal of Dermatology · 1999
    5. The Risk of Coronary Heart Disease in Men with Androgenetic Alopecia Journal of The European Academy of Dermatology and Venereology · 1999
    6. Androgenetic Alopecia in the Female Archives of Dermatology · 1994

    Related research 2

    1. Role of Low Dose Oral Minoxidil in the Treatment of Hair Loss: A Review Cosmoderma · 2021
    2. Adverse Effects of Low-Dose Oral Minoxidil for Androgenetic Alopecia in 435 Patients Journal of The American Academy of Dermatology · 2020